foxo4-dri peptide senolytic human trial ES2 rapidly destroys TP53-FOXO4 foci leading to TP53 mediated FOXO4-DRI: Human Trial Status, Cancer
Pay in 4 interest-free payments of $5.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15
























